Dr. Treister is Chief of the Divisions of Oral Medicine and Dentistry at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Treister earned his DMD from the University of Pennsylvania School of Dental Medicine and subsequently completed his Oral Medicine certificate and Oral Biology doctoral training at the Harvard School of Dental Medicine, where he is an Associate Professor of Oral Medicine in the Department of Oral Medicine, Infection and Immunity. He is board certified in Oral Medicine and practices at Brigham and Women’s Hospital and Dana-Farber Cancer Institute with special interest in oral mucosal diseases, salivary gland diseases, and oral complications in cancer patients. He has published extensively in the field of oral medicine with an emphasis on oral complications of hematopoietic cell transplantation and chronic graft-versus-host disease. Dr. Treister is currently director of HSDM's advanced graduate education oral medicine program.

Fields of Interest

Dr. Treister's clinical and research interests are focused primarily on the diagnosis and management of oral complications in cancer patients. He works closely with a number of disease programs through the Dana-Farber/Brigham and Women's Cancer Center, including Hematologic Malignancies and Stem Cell Transplantation, Head and Neck Oncology, and Sarcoma and Bone Oncology, where he actively sees patients and collaborates on numerous clinical research initiatives. The goal of his research is to better define various oral complications of cancer and cancer therapies, explore their underlying pathobiological mechanisms, and evaluate approaches to diagnosis and management with the ultimate goal of improving long-term outcomes.